,20 With the lack of efficient targeted therapy for mesothelioma and kinase inhibition being one of the most pharmacologically tractable therapeutic strategies, we performed a dropout screen against kinases in Bap1-proficient and -deficient settings. Here, BAP1 is linked to mesothelioma.